We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alternative to Animal-sourced Heparins Set for Clinical Trials

News   Sep 07, 2017 | Original story written by Mary L. Martialay for the Rensselaer Polytechnic Institute

 
Synthetic Alternative to Animal-sourced Heparins Set for Clinical Trials

Synthetic low molecular weight heparin proven safe and effective in preclinical trials. Credit: Rensselaer Polytechnic Institute

 
 
 

RELATED ARTICLES

Drug Candidate Could Recover Vocal Abilities Lost to ADNP Syndrome

News

A new Tel Aviv University study finds that the drug candidate CP201, also known as NAP, may improve vocal communication abilities that are underdeveloped in Activity-dependent neuroprotective protein (ADNP) patients.

READ MORE

New Inflammation Inhibitor Discovered

News

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.

READ MORE

Leukemia Stem Cells Rely on Amino Acids for Survival

News

Clinically relevant eradication of leukemia stem cells could be achieved with drugs that target their metabolic vulnerabilities.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE